SCHEMBL789539

SCHEMBL789539

CCC=CCOC(=O)OC(C)(C)C

nearest known ligand 0.37

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 2/20 0.37
PTGS1 P23219 1/20 0.36
NR1I2 O75469 1/20 0.33
PGR P06401 1/20 0.33
ADORA3 P0DMS8 1/20 0.33
PTGS2 P35354 1/20 0.33
PDE4D Q08499 1/20 0.33
HDAC1 Q13547 1/20 0.32
HDAC2 Q92769 1/20 0.32
ALDH1A1 P00352 3/20 0.31
CYP3A4 P08684 1/20 0.31
ALOX15 P16050 1/20 0.31
TSHR P16473 1/20 0.31
HSD17B10 Q99714 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
ELANE P08246 1/20 0.31
FFAR1 O14842 1/20 0.31
MAPT P10636 1/20 0.31
CYP19A1 P11511 1/20 0.31
RXRA P19793 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16594410 1.00 HDAC6 (0.37) HDAC6PTGS1NR1I2PGRADORA3
SCHEMBL12743336 0.92 HDAC6 (0.41) HDAC6HDAC1HDAC2ALDH1A1TDP1
SCHEMBL883432 0.92 HDAC6 (0.41) HDAC6HDAC1HDAC2ALDH1A1TDP1
SCHEMBL3139219 0.92 HDAC6 (0.41) HDAC6HDAC1HDAC2ALDH1A1TDP1
SCHEMBL3698014 0.84 HDAC6 (0.37) HDAC6HDAC1HDAC2ELANECTSK
SCHEMBL15121261 0.83 ALDH1A1 (0.46) PTGS1NR1I2PGRADORA3PTGS2
SCHEMBL14775231 0.83 ALDH1A1 (0.46) PTGS1NR1I2PGRADORA3PTGS2
SCHEMBL6016032 0.82 HDAC6 (0.41) HDAC6HDAC1HDAC2ELANECTSK
SCHEMBL6016036 0.82 HDAC6 (0.41) HDAC6HDAC1HDAC2ELANECTSK
SCHEMBL4757856 0.80 ATM (0.43) HDAC6ALDH1A1TSHRTDP1ELANE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180162905-A1 MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS ENANTA PHARM INC (US) 2018-06-14 US disclosed
US-20170088583-A1 MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS ENANTA PHARM INC (US) 2017-03-30 US disclosed
US-9439422-B2 Use of macrocyclic picolinamides as fungicides DOW AGROSCIENCES LLC (US) 2016-09-13 US disclosed
EP-3052490-A1 MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY Dow AgroSciences LLC (US) 2016-08-10 EP disclosed
EP-3052491-A1 USE OF MACROCYLIC PICOLINAMIDES AS FUNGICIDES Dow AgroSciences LLC (US) 2016-08-10 EP disclosed
US-9220748-B2 Macrocyclic proline derived HCV serine protease inhibitors ENANTA PHARMACEUTICALS, INC. (US) 2015-12-29 US disclosed
US-9179674-B2 Macrocyclic picolinamide compounds with fungicidal activity DOW AGROSCIENCES LLC (US) 2015-11-10 US disclosed
WO-2015050819-A1 USE OF MACROCYLIC PICOLINAMIDES AS FUNGICIDES DOW AGROSCIENCES LLC (US) 2015-04-09 WO disclosed
WO-2015050818-A1 MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY DOW AGROSCIENCES LLC (US) 2015-04-09 WO disclosed
US-20150094340-A1 USE OF MACROCYCLIC PICOLINAMIDES AS FUNGICIDES DOW AGROSCIENCES LLC 2015-04-02 US disclosed
US-20150094339-A1 MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY DOW AGROSCIENCES LLC 2015-04-02 US disclosed
US-20140194350-A1 MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS ENANTA PHARMACEUTICALS, INC. (US) 2014-07-10 US disclosed
US-20120070416-A1 Macrocyclic Proline Derived HCV Serine Protease Inhibitors ENANTA PHARMACEUTICALS, INC. 2012-03-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170088583-A1 MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS PREP, PRSS1, PEPD HDAC6 731/4885PTGS1 697/4885NR1I2 1036/4885
US-20150094339-A1 MACROCYCLIC PICOLINAMIDE COMPOUNDS WITH FUNGICIDAL ACTIVITY FKBP1A, FKBP14, FKBP2 HDAC6 113/4885PTGS1 1826/4885NR1I2 538/4885
US-20120070416-A1 Macrocyclic Proline Derived HCV Serine Protease Inhibitors PREP, PRSS1, PEPD HDAC6 731/4885PTGS1 697/4885NR1I2 1036/4885
US-20140194350-A1 MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS PREP, PRSS1, PEPD HDAC6 731/4885PTGS1 697/4885NR1I2 1036/4885
US-20150094340-A1 USE OF MACROCYCLIC PICOLINAMIDES AS FUNGICIDES FKBP14, CYP4F12, CYP1A2 HDAC6 434/4885PTGS1 2947/4885NR1I2 167/4885
US-20180162905-A1 MACROCYCLIC PROLINE DERIVED HCV SERINE PROTEASE INHIBITORS PREP, PRSS1, PEPD HDAC6 731/4885PTGS1 697/4885NR1I2 1036/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.